187 related articles for article (PubMed ID: 11574594)
1. Evaluation of efficiency of screening extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in hospitals where the bacteria are increasingly prevalent.
Lee K; Lim JK; Yong D; Yum J; Chong Y; Okamoto R; Inoue M
J Clin Microbiol; 2001 Oct; 39(10):3696-9. PubMed ID: 11574594
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
3. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
Basak S; Mallick SK; Bose S
J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
[TBL] [Abstract][Full Text] [Related]
4. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
5. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Bishara J; Livne G; Ashkenazi S; Levy I; Pitlik S; Ofir O; Lev B; Samra Z
Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461
[TBL] [Abstract][Full Text] [Related]
7. Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria.
Markovska R; Schneider I; Keuleyan E; Bauernfeind A
Clin Microbiol Infect; 2004 Aug; 10(8):752-5. PubMed ID: 15301679
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
Koksal F; Ak K; Kucukbasmaci O; Samasti M
Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.
Yu Y; Zhou W; Chen Y; Ding Y; Ma Y
Chin Med J (Engl); 2002 Oct; 115(10):1479-82. PubMed ID: 12490091
[TBL] [Abstract][Full Text] [Related]
10. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
11. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
Polwichai P; Trakulsomboon S; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Buppanharun W
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
[TBL] [Abstract][Full Text] [Related]
12. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
13. Genetic characterisation of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia.
Abbassi MS; Torres C; Achour W; Vinué L; Sáenz Y; Costa D; Bouchami O; Ben Hassen A
Int J Antimicrob Agents; 2008 Oct; 32(4):308-14. PubMed ID: 18620848
[TBL] [Abstract][Full Text] [Related]
14. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
Steward CD; Rasheed JK; Hubert SK; Biddle JW; Raney PM; Anderson GJ; Williams PP; Brittain KL; Oliver A; McGowan JE; Tenover FC
J Clin Microbiol; 2001 Aug; 39(8):2864-72. PubMed ID: 11474005
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.
Liao CH; Sheng WH; Wang JT; Sun HY; Wang HK; Hsueh PR; Chen YC; Chang SC
J Microbiol Immunol Infect; 2006 Feb; 39(1):59-66. PubMed ID: 16440125
[TBL] [Abstract][Full Text] [Related]
16. Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea.
Jeong SH; Bae IK; Kwon SB; Lee JH; Jung HI; Song JS; Jeong BC; Kim SJ; Lee SH
Lett Appl Microbiol; 2004; 39(1):41-7. PubMed ID: 15189286
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae.
Lee K; Hong SG; Park YJ; Lee HS; Song W; Jeong J; Yong D; Chong Y
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):319-23. PubMed ID: 16269222
[TBL] [Abstract][Full Text] [Related]
18. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
Shanthi M; Sekar U
J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
[TBL] [Abstract][Full Text] [Related]
19. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
Ryoo NH; Kim EC; Hong SG; Park YJ; Lee K; Bae IK; Song EH; Jeong SH
J Antimicrob Chemother; 2005 Oct; 56(4):698-702. PubMed ID: 16141280
[TBL] [Abstract][Full Text] [Related]
20. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea.
Kim J; Lim YM; Rheem I; Lee Y; Lee JC; Seol SY; Lee YC; Cho DT
FEMS Microbiol Lett; 2005 Apr; 245(1):93-8. PubMed ID: 15796985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
